Exelixis Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$130.88 | Buy/Sell | $130.51 | 9.26% | 11 | $331.49B |
| ROG | Roche Holding | Hold |
16
|
CHF234.80 | Buy/Sell | CHF307.83 | 16.06% | 9 | CHF189.54B |
| PFE | Pfizer | Outperform |
2
|
$28.92 | Buy/Sell | $32.87 | 5.46% | 6 | $163.88B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$967.98 | Buy/Sell | $961.26 | 8.47% | 8 | $104.43B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.11 | Buy/Sell | $58.15 | 22.42% | 10 | $89.42B |
| BAYN | Bayer | Hold |
5
|
28.65€ | Buy/Sell | 45.15€ | 4.71% | 4 | 28.15€B |
| 4523 | Eisai | Outperform |
18
|
¥6.87k | Buy/Sell | ¥9.58k | 22.34% | 0 | ¥1.97T |
| INCY | Incyte | Outperform |
9
|
$56.86 | Buy/Sell | $77.05 | 38.06% | 8 | $12.01B |
| JAZZ | Jazz Pharmaceuticals | Outperform |
14
|
$110.49 | Buy/Sell | $188.32 | 70.15% | 4 | $7.13B |
| BPMC | Blueprint Medicines | Outperform |
6
|
$106.64 | Buy/Sell | $85.71 | 12.53% | 5 | $6.78B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$37.62 | Buy/Sell | $55.60 | 59.49% | 3 | $5.76B |